Abstract 14033: Echo-MRI Discordance in Indexed Left Ventricular End-Systolic Volume Predicts Adverse Outcomes in Chronic Valvular Regurgitation
Abstract
Background: Echocardiography and cardiac magnetic resonance imaging (MRI) are routinely used to assess ventricular remodeling in chronic valvular regurgitation. However, substantial discrepancies between echocardiographic and cardiac MRI derived left ventricular end-systolic volume index (LVESVi) measurements are frequently observed. The clinical significance of this discordance remains poorly understood. We sought to determine whether Echo–MRI LVESVi discrepancy is associated with adverse clinical outcomes. Methods: We retrospectively studied patients with moderate-or-greater aortic regurgitation (AR) or mitral regurgitation (MR) who underwent both echocardiography and cardiac MRI within a mean duration of 3 months. LVESVi discrepancy was defined as the absolute difference between echocardiographic and CMR-derived LVESVi measurements. The primary outcome was a composite of heart failure hospitalization and all-cause mortality. Multivariable Cox proportional hazards models were constructed adjusting for sex, age, body surface area (BSA), regurgitant fraction (MRI-RF), valve lesion type (AR versus MR), and time-dependent surgery. Kaplan–Meier analyses were performed after stratification by sex and mean LVESVi discrepancy. Results: A total of 741 patients were included (531 AR, and 210 MR). Echo underestimated LV linear dimensions and volumes compared to MRI, while overestimating EF in both AR and MR (Table 1). Greater Echo–MRI LVESVi discrepancy was associated with increasing MRI LVESVi and was more pronounced among women at higher levels of ventricular remodeling (Fig1). During follow-up, Echo–CMR LVESVi discrepancy independently predicted the composite outcome (HR 1.010 per 1 mL/m 2 increase; 95% CI 1.000–1.019; p=0.044), even after adjustment for age, sex, body size, regurgitant severity, disease type, and surgery. Female sex remained independently associated with adverse outcomes (HR 2.49; 95% CI 1.41–4.41; p=0.002), and increasing age was also a significant predictor (HR 1.05 per year; 95% CI 1.03–1.06; p<0.001). Kaplan–Meier analysis demonstrated progressive separation of survival curves according to sex and LVESVi discrepancy (mean 19.93 ml/m 2 ), with women exhibiting the worst event-free survival when discrepancy exceeded the cohort mean (pairwise log-rank p=0.036) (Fig 2). Conclusions: Echo–MRI LVESVi discrepancy independently predicts primary composite outcome beyond age, sex, body size, regurgitant severity, and surgery. These findings suggest that reliance on echocardiography alone may underestimate risk in selected patients, particularly women, and support a greater role for CMR in identifying high-risk individuals with chronic valvular regurgitation.